Screener
60 Degrees Pharmaceuticals SXTP Q1 2025 earnings
Reported May 15, 2025 · Before market open
Revenue$163.6KMiss by $136.4K
EPS-$1.56Miss by $0.25
Revenue estimate$300.0K
EPS estimate-$1.31
Next report
Nov 12, 2026 (in 2 months)Revenue estimate$270.0K
EPS estimate-$0.61
Versus estimates
Revenue
Diluted EPS
FAQ
- When did 60 Degrees Pharmaceuticals report Q1 2025 earnings?
- 60 Degrees Pharmaceuticals (SXTP) reported Q1 2025 earnings on May 15, 2025 before market open.
- What were 60 Degrees Pharmaceuticals's Q1 2025 revenue and EPS?
- 60 Degrees Pharmaceuticals reported revenue of $163.6K and eps of $-1.56 for Q1 2025.
- Did 60 Degrees Pharmaceuticals beat estimates in Q1 2025?
- Revenue missed the consensus estimate of $300.0K by $136.4K. EPS missed the consensus estimate of $-1.31 by $0.25.
- How did 60 Degrees Pharmaceuticals's Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue grew 54.8% from $105.7K a year earlier.
- Where can I find 60 Degrees Pharmaceuticals's Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0001213900-25-043779) directly on SEC EDGAR. The filing index links above go to sec.gov.
